Why Is Everyone Talking About Inovio Pharmaceuticals Stock?
Even after dipping into bear market territory last week, the stock market continues to fall due to fears surrounding the COVID-19 outbreak. On Monday, the S&P 500 fell by 12%, its biggest one-day drop since 1987. Meanwhile, the Dow Jones plunged by 13% that day. What's more, there's no telling how long the pandemic will last, with U.S. President Donald Trump recently warning that a full-blown recession may be on the horizon.
Despite all this chaos, though, some stocks have performed well and have generated quite a buzz. One of these stocks is Inovio Pharmaceuticals (NASDAQ: INO), a biotech company that focuses on developing DNA medicines to treat cancers and infectious diseases. It's worth investigating why Inovio has made so many headlines of late, and whether investors should consider buying shares of the company now.
Image Source: Getty Images
Source Fool.com